Bottneuro publishes Whitepaper | Bottneuro

Bottneuro publishes Whitepaper

Posted on 23 January, 2024

"Bottneuro is at the forefront of portable, personalized brain diagnostic and treatment for patients with neurological and psychiatric conditions. Their customized headset allows for simultaneous recording and modulation of brain oscillatory activity, enabling unprecedented interaction with individual brain patterns. Bottneuro’s precision technology is proving crucial in enabling research and validation of potential treatments for conditions such as Alzheimer’s disease, depression and pain, bringing personalized neuromodulation to patients’ home." - Prof. Emiliano Santarnecchi, Harvard Medical School & Massachusetts General Hospital

Read more about the technology, our customized Miamind® Neurostimulator and the opportunity the recent registration at Swissmedic and MHRA offers in our whitepaper by Alois C. Hopf, PhD!

Thanks to our scientific advisors, Prof. Emiliano Santarnecchi from the Harvard Medical School and Prof. Christoph Michel from the University of Geneva for their continuous support in bringing the personalized Miamind® Neurostimulator and transcranial electrical stimulation to the patients in need.

👉 download the full white paper here!

We use cookies to personalize content and to analyze our traffic. Please decide if you are willing to accept cookies from our website.